Thursday 21 June 2018 ,
Latest News
  • 'Sex trafficking of Rohingya children in Bangladesh'
  • EC takes massive preparation for GCC polls
  • Bangladesh registers 2nd largest number of refugees in 2017: UNHCR
  • Record 68.5 million people displaced worldwide: UN
  • Thousands marooned in Sylhet flood
  • BNP to stage demo across country Thursday
  • All eyes on Salah as hopeful Egypt take on Russia
6 December, 2017 12:23:29 AM / LAST MODIFIED: 6 December, 2017 10:33:52 AM

Print

Philippines halts Sanofi’s dengue vaccine sale

AFP
Philippines halts Sanofi’s dengue vaccine sale

The Philippines has suspended the sale and distribution of Sanofi's dengue vaccine, authorities said yesterday, after the French pharmaceutical giant last week warned it could worsen symptoms for people who had not previously been infected, reports AFP from Manila. Regulators on Friday froze the country's world-first public dengue immunisation programme that has seen more than 733,000 children receive the Dengvaxia vaccine.

Authorities have now ordered a blanket suspension for private use as well. “Whether (the vaccine) is used in the public health programme or used by a private practitioner, it is the same product that was licensed. Everyone is covered by the FDA advisory,” health undersecretary Gerardo Bayugo told the news agency.IFrame The Philippine Food and Drug Administration (FDA), a regulatory agency under the health department, said in a public advisory on Monday it had pulled the vaccine from the market to “protect the general public”.

“The (FDA) immediately directed Sanofi to suspend the sale/distribution/marketing of Dengvaxia and cause the withdrawal of Dengvaxia in the market pending compliance with the directives of the FDA,” the advisory said.

Sanofi’s announcement has caused major fears in the Philippines — where the mosquito-born disease is extremely prevalent — particularly for parents of the children immunised in the public programme.

More than 1,000 people in the Philippines died from dengue last year, out of more than 211,000 suspected cases, according to the government.

Sanofi on Monday sought to allay fears about the new study that led it to release the warning, saying Dengvaxia would not cause anyone who was immunised to die.

Philippine authorities have given conflicting messages on the safety or otherwise of the vaccine.

Presidential spokesman Harry Roque said Sunday that the government would “leave no stone unturned” in making those responsible for putting “hundreds of thousands of young lives at risk” accountable for their actions.

The justice department then on Monday formally launched an inquiry over “the alleged danger to public health”.

But Roque also said on Monday there was “no danger” for people who had been immunised with Dengvaxia.

“The worst that can happen is for those who have not had dengue before... they may get infected with dengue but falling under our previous classification of ‘mild’, having fever and bruises,” Roque said.

When asked to comment on the Philippine government’s decision to suspend all sales of Dengvaxia, Sanofi said on Tuesday it would continue to work with authorities and highlighted its proposal to re-label the vaccine.

SR

 

Comments

Poll
Today's Question »
CEC Nurul Huda yesterday said law and order situation in Gazipur was stable and that army was not needed for city polls there. Do you agree with the CEC?
 Yes
 No
 No Comment
Yes 22.7%
No 77.3%
No Comment 0.0%
Video

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting